Microangiopathic hemolytic anemia


Microangiopathic hemolytic anemia
Microangiopathic hemolytic anemia
Classification and external resources
ICD-10 D59.4
ICD-9 283.19
DiseasesDB 29721

In medicine (hematology) microangiopathic hemolytic anemia (MAHA) is a microangiopathic subgroup of hemolytic anemia (loss of red blood cells through destruction) caused by factors in the small blood vessels. It is identified by the finding of anemia and schistocytes on microscopy of the blood film.

Presentation

It is referred as Runner's anemia. In diseases such as hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, as well as malignant hypertension, the endothelial layer of small vessels is damaged with resulting fibrin deposition and platelet aggregation. As red blood cells travel through these damaged vessels, they are fragmented resulting in intravascular hemolysis. The resulting schistocytes (helmet cells) are also increasingly targeted for destruction by the reticuloendothelial system in the spleen, due to their narrow passage through obstructed vessel lumina. It is seen in systemic lupus erythematosus because the immune complex aggregates with platelets, which creates intravascular thrombi.

Automated analysers (the machines that perform routine full blood counts in most hospitals) are generally programmed to flag blood films that display red blood cell fragments or schistocytes.

Pathophysiology

In all causes, the mechanism of MAHA is the formation of a fibrin mesh due to increased activation of the system of coagulation. The red blood cells are physically cut by these protein networks, and the fragments are identical to the schistocytes seen on light microscopy.

References


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Hemolytic anemia — ICD9|283, ICD9|773 ICDO = OMIM = MedlinePlus = 000571 eMedicineSubj = med eMedicineTopic = 979 MeshID = D000743Hemolytic anemia is anemia due to hemolysis, the abnormal breakdown of red blood cells (RBCs) either in the blood vessels… …   Wikipedia

  • Mechanical hemolytic anemia — is a form of hemolytic anemia due to mechanically induced damage to red blood cells. Red blood cells, while flexible, may in some circumstances succumb to physical shear and compression.[1] This may result in hemoglobinuria. Some forms are self… …   Wikipedia

  • hemolytic uremic syndrome — n any of a group of rare disorders that are characterized by microangiopathic hemolytic anemia, thrombocytopenia, and varying degrees of kidney failure, that are precipitated by a variety of etiologic factors (as infection with toxin producing… …   Medical dictionary

  • microangiopathic anemia — microangiopathic hemolytic anemia thrombotic thrombocytopenic purpura …   Medical dictionary

  • Hemolytic-uremic syndrome — Infobox Disease Name = PAGENAME Caption = DiseasesDB = 13052 ICD10 = ICD10|D|59|3|d|55 ICD9 = ICD9|283.11 ICDO = OMIM = 235400 MedlinePlus = eMedicineSubj = ped eMedicineTopic = 960 MeshID = D006463 In medicine, hemolytic uremic syndrome (or… …   Wikipedia

  • Anemia — For other uses, see Anemia (disambiguation). Anemia Classification and external resources ICD 10 D50 D64 ICD 9 …   Wikipedia

  • Anemia — The condition of having less than the normal number of red blood cells or less than the normal quantity of hemoglobin in the blood. The oxygen carrying capacity of the blood is, therefore, decreased. Persons with anemia may feel tired and fatigue …   Medical dictionary

  • microangiopathic haemolytic anaemia — (= m. hemolytic anemia (USA) ) Consequence of disseminated intravascular coagulation (DIC) : fragments of red blood cells, damaged by being forced through a fibrin meshwork, are found in the circulation …   Dictionary of molecular biology

  • MAHA — microangiopathic hemolytic anemia …   Medical dictionary

  • MAHA — • microangiopathic hemolytic anemia …   Dictionary of medical acronyms & abbreviations


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.